A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathway

Our identification of dysregulation of the AKT pathway in ovarian cancer as a platinum resistance specific event led to a comprehensive analysis of in vitro, in vivo and clinical behaviour of the AKT inhibitor GSK2141795. Proteomic biomarker signatures correlating with effects of GSK2141795 were dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheraghchi-Bashi, Azadeh, Parker, Christine A., Curry, Ed, Salazar, Jean-Frederic, Gungor, Hatice, Saleem, Azeem, Cunnea, Paula, Rama, Nona, Salinas, Cristian, Mills, Gordon B., Morris, Shannon R., Kumar, Rakesh, Gabra, Hani, Stronach, Euan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747185/
https://www.ncbi.nlm.nih.gov/pubmed/26497682

Ejemplares similares

Ejemplares similares